Loading clinical trials...
Loading clinical trials...
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the French, Italian and Spanish Versions of the PAH-SYMPACT™
Conditions
Interventions
Macitentan
Locations
39
France
Hôpital de Haut Levêque
Bordeaux, France
Hôpital Côte de Nacre
Caen, France
Hôpital Albert Michallon
Grenoble, France
CHU de Bicêtre
Le Kremlin-Bicêtre, France
CHRU Lille - Hôpital Cardiologique
Lille, France
Hôpital Louis Pradel
Lyon, France
Start Date
March 1, 2014
Primary Completion Date
October 1, 2015
Completion Date
November 1, 2015
Last Updated
March 21, 2018
NCT07218029
NCT06649110
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
Actelion
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions